Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty

ISSN： 1170-229X

Source： Drugs & Aging, Vol.13, Iss.4, 1998-10, pp. : 291-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucocorticoids in the Prevention of Restenosis After Coronary Angioplasty: Therapeutic Potential

By Ferrero Valeria Ribichini Flavio Pesarini Gabriele Brunelleschi Sandra Vassanelli Corrado

Drugs, Vol. 67, Iss. 9, 2007-01 ,pp. : 1243-1255

Adis International

Access to resources Recommend Favorite

Photopheresis: Therapeutic Potential in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty

By Bisaccia E.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 43-51

Adis International

Access to resources Recommend Favorite

Pharmacological treatment for prevention of restenosis

By Linde Jacek Strauss Bradley H

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 281-302

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological prevention and management of restenosis

By Tiroch Klaus A Byrne Robert A Kastrati Adnan

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1855-1872

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches for the prevention of restenosis

By Gruberg L. Waksman R. Satler L.F. Pichard A.D. Kent K.M.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2555-2578

Informa Healthcare

Access to resources Recommend Favorite